Alison is a senior news reporter covering US politics and legal news. Musk said on X early Monday he would “give one of my SpaceX shares to every kid in America” next year, promising those shares ...
Medicare open enrollment is in full swing for beneficiaries who are part of the federal program, but whether it will cost more overall is still unclear. The 2026-27 open enrollment period began ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Revolution Medicines recently made history with the approval of its RAS inhibitor Rasonque for advanced pancreatic cancer. But behind RevMed is an entire field of biotechs working to broaden the reach ...
In an endlessly impressive filmography either as a screenwriter for Martin Scorsese-directed classics like Taxi Driver, The Last Temptation of Christ and Raging Bull, to his own prodigious output as a ...
The U.S. Food and Drug Administration (FDA) has approved daraxonrasib, an oral multi-selective RAS(ON) inhibitor, for adults with metastatic pancreatic adenocarcinoma who have received at least one ...
The FDA approved daraxonrasib, the first targeted therapy for metastatic pancreatic adenocarcinoma, citing a survival benefit vs chemotherapy. The FDA approved daraxonrasib (Rasonque; Revolution ...
The incredible journey of Parker Byrd, who made history as the first modern-era NCAA Division I baseball player to take the field with a prosthetic leg after a near-fatal boating accident. This ...
Unmanned Surface Vessel Division 12 (Sea Hunter) and 13 (Sea Hunter) conduct unit level training underway in San Diego Bay, California, May 1, 2025. US Navy photo The Navy’s portfolio acquisition ...
A STAT investigation found that older women paid up to $30,000 for overseas mitochondrial replacement therapy, despite limited evidence that three-parent IVF improves fertility or addresses ...
The Centers for Medicare & Medicaid Services has announced the end of Part D subsidies for standalone prescription drug plans. CMS will discontinue the Part D Premium Stabilization Demonstration at ...